BioMarin Pharmaceutical Inc. reaffirmed earnings guidance for the year 2024. For the year, the company expects there is no change in total revenues.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.07 USD | +0.79% | -0.60% | -22.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.14% | 14.25B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-17.66% | 7.32B | |
+88.73% | 7.14B |
- Stock Market
- Equities
- BMRN Stock
- News BioMarin Pharmaceutical Inc.
- Biomarin Pharmaceutical Inc. Reaffirms Earnings Guidance for the Year 2024